Veeco: Undervalued, Despite Critical Role In AI And Advanced Semiconductor Manufacturing — Positive
VECO Seeking Alpha — July 23, 2025Veeco's strategic pivot to advanced packaging, GAA, and EUV infrastructure aligns it with secular semiconductor trends, driving multi-year growth and margin expansion. Strong pipeline conversion, Tier 1 customer wins, and differentiated platforms like LSA and IBD300 underpin revenue visibility and position Veeco for outsized growth. Despite temporary margin headwinds from tariffs and logistics, operational discipline and favorable product mix support a robust margin expansion outlook from FY26 onward.
Tradeweb generates close to 50% FCF margins, has zero debt, and a huge market share in electronic bond and rates trading. Its fee model, tied to trading volumes, provides a natural inflation hedge and strong operating leverage as the market expands globally. Global debt levels and trading activity are at all-time highs, supporting fast revenue growth and margin expansion.
MDST: Active Midstream ETF, Double-Digit Distribution Yield, Below-Average Returns — Positive
MDST Seeking Alpha — July 23, 2025MDST is an actively-managed, midstream energy ETF selling covered calls. MDST's 10.2% distribution yield is incredibly strong, but its covered call strategy caps upside and leads to underperformance in bull markets. The fund compares unfavorably to other midstream energy funds, and covered call funds, on several important metrics.
ManpowerGroup Stock Improves 5% Since Q2 Earnings Beat — Positive
MAN Zacks Investment Research — July 23, 2025MAN tops Q2 EPS and revenue estimates, but a 40% profit drop and an operating loss weigh on sentiment.
Marvell Technology's Optics Business Expands: What's on the Horizon? — Positive
MRVL Zacks Investment Research — July 23, 2025MRVL's optics business gains speed with AI-driven demand, co-packaged upgrades, and soaring revenue growth.
A Closer Look at the Top IPOs of 2025: CRCL, CRWV — Positive
CRCL CRWV Zacks Investment Research — July 23, 2025The re-awakening of the IPO market is certainly notable, signaling renewed investor confidence and a meaningful shift in broader risk appetites.
The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug Blenrep as a combination treatment, the company said on Wednesday.
Hasbro, Inc. (NASDAQ:HAS ) Q2 2025 Earnings Conference Call July 23, 2025 8:30 AM ET Company Participants Christian P. Cocks - CEO & Director Fred Wightman - Corporate Participant Gina Goetter - CFO & COO Conference Call Participants Stephen Neild Laszczyk - Goldman Sachs Group, Inc., Research Division Alexander Thomas Perry - BofA Securities, Research Division Arpine Kocharyan - UBS Investment Bank, Research Division Christopher Michael Horvers - JPMorgan Chase & Co, Research Division Eric Owen Handler - ROTH Capital Partners, LLC, Research Division Jaime M.
Texas Instruments stock falls 12% as CEO warns of tariff concerns — Negative
TXN CNBC — July 23, 2025Texas Instruments shares dropped after the company issued weak earnings guidance and said uncertainty over tariffs has weighed on demand. The midpoint of the company's third-quarter earnings forecast came up short of analyst expectations.
Thermo Fisher Scientific Stock Jumps on Strong Results, Higher Outlook — Positive
TMO Investopedia — July 23, 2025Thermo Fisher Scientific (TMO) shares took off after the maker of lab equipment and other life sciences products posted better-than-expected results and boosted its guidance, citing operational improvements and lower expected impacts from new tariffs.
Vir Biotechnology: Hep B And Cancer Projects March On
Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript — Neutral
BSX Seeking Alpha — July 23, 2025Boston Scientific Corporation (NYSE:BSX ) Q2 2025 Earnings Conference Call July 23, 2025 8:00 AM ET Company Participants Jonathan R. Monson - Executive VP & CFO Kenneth M.
KO's Strategic Pricing Drives Q2 Beat: What's Next for Investors? — Positive
KO Zacks Investment Research — July 23, 2025Coca-Cola beats Q2 estimates as pricing power offsets volume dip, with premium products and strategic execution fueling gains.
Veralto Gears Up to Report Q2 Earnings: Here's What You Should Know — Positive
VLTO Zacks Investment Research — July 23, 2025VLTO to report Q2 results, with EPS and revenues expected to rise on Water Quality strength and solid operating efficiency.
Dave vs. OppFi: Which Fintech Stock is the Smarter Bet Right Now? — Positive
DAVE OPFI Zacks Investment Research — July 23, 2025Both OppFi Inc. OPFI and Dave DAVE operate in the fintech space, addressing customer needs encircling digital lending. DAVE's primary service is to offer small, interest-free cash advances to users.
5 Stocks Powering the S&P 500 ETF So Far in 2025 — Positive
SPY Zacks Investment Research — July 23, 2025Five stocks, PLTR, NRG, STX and HWM, have surged over 60%, powering SPY's climb to all-time highs in 2025.
Fiserv, Inc. (NYSE:FI ) Q2 2025 Earnings Conference Call July 23, 2025 8:00 AM ET Company Participants Julie Chariell - Senior Vice President of Investor Relations Michael Patrick Lyons - CEO, President & Director Robert W. Hau - Chief Financial Officer Conference Call Participants Andrew William Jeffrey - William Blair & Company L.L.C.
Ferrari Stock Is Racing Higher. GM and Ford Could Get Left Behind. — Positive
F GM RACE Barrons — July 23, 2025
lululemon's Premium Valuation Shows Strength: Time to Buy or Wait? — Neutral
LULU Zacks Investment Research — July 23, 2025LULU's high valuation clashes with weak U.S. demand, rising costs, margin pressures and a cautious profit outlook for fiscal 2025.
McDonald's Snack Wrap demand caused lettuce shortage at some of its restaurants — Positive
MCD Fox Business — July 23, 2025After a nine-year hiatus, McDonald's brought back the popular Snack Wrap to overwhelming customer response, causing temporary ingredient shortages across some of its restaurants.
